These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 19194909)

  • 1. A methodology for the comparative evaluation of alternative bioseparation technologies.
    Tran R; Zhou Y; Lacki KM; Titchener-Hooker NJ
    Biotechnol Prog; 2008; 24(5):1007-25. PubMed ID: 19194909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decision-support software for the industrial-scale chromatographic purification of antibodies.
    Chhatre S; Thillaivinayagalingam P; Francis R; Titchener-Hooker NJ; Newcombe AR; Keshavarz-Moore E
    Biotechnol Prog; 2007; 23(4):888-94. PubMed ID: 17630695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative bioseparation operations: life beyond packed-bed chromatography.
    Przybycien TM; Pujar NS; Steele LM
    Curr Opin Biotechnol; 2004 Oct; 15(5):469-78. PubMed ID: 15464380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-throughput process development: determination of dynamic binding capacity using microtiter filter plates filled with chromatography resin.
    Bergander T; Nilsson-Välimaa K; Oberg K; Lacki KM
    Biotechnol Prog; 2008; 24(3):632-9. PubMed ID: 18454563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case study and application of process analytical technology (PAT) towards bioprocessing: use of on-line high-performance liquid chromatography (HPLC) for making real-time pooling decisions for process chromatography.
    Rathore AS; Yu M; Yeboah S; Sharma A
    Biotechnol Bioeng; 2008 Jun; 100(2):306-16. PubMed ID: 18078292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining multiple quantitative and qualitative goals when assessing biomanufacturing strategies under uncertainty.
    Farid SS; Washbrook J; Titchener-Hooker NJ
    Biotechnol Prog; 2005; 21(4):1183-91. PubMed ID: 16080700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in primary recovery: centrifugation and membrane technology.
    Roush DJ; Lu Y
    Biotechnol Prog; 2008; 24(3):488-95. PubMed ID: 18410157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A decision-support model for evaluating changes in biopharmaceutical manufacturing processes.
    Chhatre S; Francis R; O'Donovan K; Titchener-Hooker NJ; Newcombe AR; Keshavarz-Moore E
    Bioprocess Biosyst Eng; 2007 Jan; 30(1):1-11. PubMed ID: 17093973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation of advanced technologies in commercial monoclonal antibody production.
    Zhou JX; Tressel T; Yang X; Seewoester T
    Biotechnol J; 2008 Oct; 3(9-10):1185-200. PubMed ID: 18759247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in bioprocessing application of membrane chromatography.
    Orr V; Zhong L; Moo-Young M; Chou CP
    Biotechnol Adv; 2013; 31(4):450-65. PubMed ID: 23357364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An integrated impact assessment and weighting methodology: evaluation of the environmental consequences of computer display technology substitution.
    Zhou X; Schoenung JM
    J Environ Manage; 2007 Apr; 83(1):1-24. PubMed ID: 16714079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enabling technologies: fermentation and downstream processing.
    Weuster-Botz D; Hekmat D; Puskeiler R; Franco-Lara E
    Adv Biochem Eng Biotechnol; 2007; 105():205-47. PubMed ID: 17408085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultra scale-down prediction using microwell technology of the industrial scale clarification characteristics by centrifugation of mammalian cell broths.
    Tait AS; Aucamp JP; Bugeon A; Hoare M
    Biotechnol Bioeng; 2009 Oct; 104(2):321-31. PubMed ID: 19507199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basic concepts in Q membrane chromatography for large-scale antibody production.
    Zhou JX; Tressel T
    Biotechnol Prog; 2006; 22(2):341-9. PubMed ID: 16599545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficiency and economics of bioseparation: some case studies.
    Sadana A; Beelaram AM
    Bioseparation; 1994 Aug; 4(4):221-35. PubMed ID: 7765088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medium term planning of biopharmaceutical manufacture using mathematical programming.
    Lakhdar K; Zhou Y; Savery J; Titchener-Hooker NJ; Papageorgiou LG
    Biotechnol Prog; 2005; 21(5):1478-89. PubMed ID: 16209554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A software tool to assist business-process decision-making in the biopharmaceutical industry.
    Mustafa MA; Washbrook J; Lim AC; Zhou Y; Titchener-Hooker NJ; Morton P; Berezenko S; Farid SS
    Biotechnol Prog; 2004; 20(4):1096-102. PubMed ID: 15296435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioseparation in antibody manufacturing: the good, the bad and the ugly.
    Gottschalk U
    Biotechnol Prog; 2008; 24(3):496-503. PubMed ID: 18442255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling of purification operations in biotechnology: enabling process development, optimization, and scale-up.
    Velayudhan A; Menon MK
    Biotechnol Prog; 2007; 23(1):68-73. PubMed ID: 17269673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global Sensitivity Analysis for the determination of parameter importance in bio-manufacturing processes.
    Chhatre S; Francis R; Newcombe AR; Zhou Y; Titchener-Hooker N; King J; Keshavarz-Moore E
    Biotechnol Appl Biochem; 2008 Oct; 51(Pt 2):79-90. PubMed ID: 18205624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.